Skip to main content

Table 3 Percentage of patients with declined cognitive functions among the three groups

From: The effects of neostigmine on postoperative cognitive function and inflammatory factors in elderly patients – a randomized trial

 

Control group

(n = 42)

0.04 mg/kg group

(n = 40)

0.02 mg/kg group

(n = 38)

Neostigmine

(n = 78)

Declined cognitive function (n)

14

4

6

10

Normal cognitive function (n)

28

36

32

68

Incidence (%)

33.3

10a

15.7a

12.8a

  1. aP< 0.05 in comparison with the control group